Try our beta test site

Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects (EBI-005-1)

This study has been completed.
Information provided by (Responsible Party):
Eleven Biotherapeutics Identifier:
First received: December 7, 2012
Last updated: May 6, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)